UNH SHAREHOLDER ALERT: Edelson Lechtzin LLP is Investigating Breach of Fiduciary Duty Claims on Behalf of UnitedHealth Group Incorporated (NYSE: UNH) Shareholders

Core Viewpoint - Edelson Lechtzin LLP is investigating breach of fiduciary duty claims on behalf of shareholders of UnitedHealth Group Incorporated for the period between March 14, 2022, and February 27, 2024, due to significant stock price fluctuations and insider trading allegations [1]. Company Background - UnitedHealth operates through two main segments: UnitedHealthcare, which provides health insurance, and Optum, which offers technology-enabled services to the healthcare market [2]. Claims and Legal Issues - UnitedHealth announced the acquisition of Change Healthcare on January 6, 2021, aimed at improving clinical decision-making and simplifying healthcare payment processes. Concerns were raised regarding the lack of a meaningful firewall to protect sensitive healthcare data [3]. - The U.S. Department of Justice (DOJ) initially sought to block the acquisition on antitrust grounds, arguing it would give UnitedHealth unprecedented access to sensitive patient information. However, the DOJ lost the case in September 2022, allowing the acquisition to proceed [3]. - On February 27, 2024, the DOJ reopened its antitrust investigation, focusing on insider stock sales exceeding $100 million prior to the public announcement of the merger. Following this news, UnitedHealth's stock price fell by 12%, from $525.32 to $513.42 per share, and continued to decline to $498.28 by February 28, 2024 [4].